HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $23,696,000 | -23.9% | 1,274,695 | 0.0% | 0.16% | -25.9% |
| Q1 2019 | $31,153,000 | -5.8% | 1,274,695 | 0.0% | 0.22% | -21.4% |
| Q4 2018 | $33,066,000 | -18.0% | 1,274,695 | 0.0% | 0.28% | -3.1% |
| Q3 2018 | $40,344,000 | -18.5% | 1,274,695 | 0.0% | 0.29% | -25.9% |
| Q2 2018 | $49,521,000 | +47.2% | 1,274,695 | 0.0% | 0.39% | +48.9% |
| Q1 2018 | $33,651,000 | – | 1,274,695 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|